Saudi Biotherapeutics Company
RESEARCH
Biotherapeutics combined with advances in modern science and clinical experience has been the catalyst in improved healthcare treatments using increasingly sophisticated therapies to address the knowledge gap. Research trends include:
-
Bispecific and conjugated monoclonal antibody products;
-
Exploration of recombinant protein-based therapeutics;
-
Analysis of heterogenous biological products that are manufactured by living organisms as an ensemble of related species; and
-
Liquid chromatography-mass spectrometry (LC-MS) vs Host cell Protein (HCP) ELISA techniques and possibilities
Pushing the Scientific Boundaries
Interesting Fact
Around 10,000 human cells could fit on a pin head and a drop of blood contains around 250,000 platelets.
At Madarik we provide patients in Saudi, GCC and North Africa with innovative medical treatments. We harness the body’s ability to heal itself, autologous biological therapies such as the proprietary RAPID™ Biodynamic Haematogel, use concentrated platelets derived from the patient’s own blood, which are activated by autologous thrombin to release growth factors, cell signallers and proteins that work at a cellular level to stimulate the patient’s own healing process.
Biotherapeutics are a Catalyst to Change
Over the last 30 years, biotherapeutics have revolutionized modern medicine. First used in Insulin to treat diabetics and regulate their blood sugar, they are now used to treat serious illnesses including cancer, heart disease, multiple sclerosis, anaemia and rheumatoid arthiritis.